SEARCH

SEARCH BY CITATION

  • 1
    Taylor RP, Horgan C, Buschbacher R, Brunner CM, Hess CE, O'Brien WM, et al. Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum 1983; 26: 73644.
  • 2
    Kiss E, Csipo I, Cohen JH, Reveil B, Kavai M, Szegedi G. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus. Autoimmunity 1996; 25: 538.
  • 3
    Miot S, Marfurt J, Lach-Trifilieff E, Gonzalez-Rubio C, Lopez-Trascasa M, Sadallah S, et al. The mechanism of loss of CR1 during maturation of erythrocytes is different between factor I deficient patients and healthy donors. Blood Cells Mol Dis 2002; 29: 20012.
  • 4
    Pascual M, Duchosal MA, Steiger G, Giostra E, Pechere A, Paccaud JP, et al. Circulating soluble CR1 (CD35): serum levels in diseases and evidence for its release by human leukocytes. J Immunol 1993; 151: 170211.
  • 5
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 6
    Cohen JH, Atkinson JP, Klickstein LB, Oudin S, Subramanian VB, Moulds JM. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphism. Mol Immunol 1999; 36: 81925.
  • 7
    Nardin A, Lindorfer NA, Taylor RP. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells? Mol Immunol 1999; 36: 82735.
  • 8
    Craig ML, Waitumbi JN, Taylor RP. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1. J Immunol 2005; 174: 305966.
  • 9
    Kiss E, Kavai M, Csipo I, Szegedi G. Recombinant human erythropoietin modulates erythrocyte complement receptor 1 functional activity in patients with lupus nephritis. Clin Nephrol 1998; 49: 3649.
  • 10
    Csipo I, Kiss E, Soltesz P, Antal-Szalmas P, Szegedi G, Cohen JH, et al. Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1999; 118: 45864.
  • 11
    Sadallah S, Hess C, Trendelenburg M, Vedeler C, Lopez-Trascasa M, Schifferli JA. Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients. Clin Exp Immunol 2003; 131: 17481.